Adapalene NDC 45802-453

NDC codes

FDA NDC Directory

Product NDC (as listed)45802-453Labeler and product segments. Claims need a package NDC.

Product NDC at billing width45802-0453Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
45802-453-84	45802045384	1 TUBE in 1 CARTON (45802-453-84) / 45 g in 1 TUBEMarketed from Oct 27, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — .1 g/100g
Dosage form: Cream
Route: Topical
Labeler: Padagis Israel Pharmaceuticals Ltd
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020748
Marketing start: Oct 26, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 45802-453_0a564c3c-85dd-4fb8-8bb8-27a9e24c5723SPL ID 0a564c3c-85dd-4fb8-8bb8-27a9e24c5723SPL set ID 94cf9af1-afab-4064-a2ca-619b54218262RxCUI 313852UNII 1L4806J2QF
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N445802045384 followed by a unit qualifier and the quantity

Package 45802-0453-84. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 25, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Adapalene Cream, 0.1% is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)